CN115768801A - 工程化松弛素及其使用方法 - Google Patents

工程化松弛素及其使用方法 Download PDF

Info

Publication number
CN115768801A
CN115768801A CN202180033724.4A CN202180033724A CN115768801A CN 115768801 A CN115768801 A CN 115768801A CN 202180033724 A CN202180033724 A CN 202180033724A CN 115768801 A CN115768801 A CN 115768801A
Authority
CN
China
Prior art keywords
amino acid
acid sequence
seq
fusion protein
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180033724.4A
Other languages
English (en)
Chinese (zh)
Inventor
A·克鲁塞
S·C·伊兰德森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of CN115768801A publication Critical patent/CN115768801A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CN202180033724.4A 2020-05-08 2021-05-07 工程化松弛素及其使用方法 Pending CN115768801A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063021814P 2020-05-08 2020-05-08
US63/021,814 2020-05-08
PCT/US2021/031260 WO2021226439A2 (en) 2020-05-08 2021-05-07 Engineered relaxins and methods of use thereof

Publications (1)

Publication Number Publication Date
CN115768801A true CN115768801A (zh) 2023-03-07

Family

ID=78468429

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180033724.4A Pending CN115768801A (zh) 2020-05-08 2021-05-07 工程化松弛素及其使用方法

Country Status (10)

Country Link
US (1) US20230174610A1 (cg-RX-API-DMAC7.html)
EP (1) EP4146681A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023524981A (cg-RX-API-DMAC7.html)
KR (1) KR20230008791A (cg-RX-API-DMAC7.html)
CN (1) CN115768801A (cg-RX-API-DMAC7.html)
AU (1) AU2021268355A1 (cg-RX-API-DMAC7.html)
CA (1) CA3180662A1 (cg-RX-API-DMAC7.html)
IL (1) IL297951A (cg-RX-API-DMAC7.html)
MX (1) MX2022013770A (cg-RX-API-DMAC7.html)
WO (1) WO2021226439A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023086913A2 (en) 2021-11-11 2023-05-19 Tectonic Therapeutic, Inc. Relaxin-2 fusion protein analogs and methods of using same
JP2024546877A (ja) * 2021-12-15 2024-12-26 メドイミューン・リミテッド ヘテロ二量体リラキシン融合物を使用した治療
EP4713001A2 (en) * 2023-05-18 2026-03-25 Tectonic Operating Company, Inc. Relaxin-2 fusion protein analogs and methods of using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130237481A1 (en) * 2010-08-17 2013-09-12 Vadim Kraynov Modified relaxin polypeptides and their uses
CN110225924A (zh) * 2017-01-25 2019-09-10 免疫医疗公司 松弛素融合多肽及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
US20110245469A1 (en) * 2010-04-02 2011-10-06 Athena Discovery, Inc. Intermediates formed in biosynthesis of relaxin-fusion proteins with extended in vivo half-lives
AU2012280474A1 (en) * 2011-07-01 2014-01-16 Bayer Intellectual Property Gmbh Relaxin fusion polypeptides and uses thereof
WO2015038938A1 (en) * 2013-09-13 2015-03-19 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
CN115837014A (zh) * 2016-05-18 2023-03-24 摩登纳特斯有限公司 编码松弛素的多核苷酸
SG10201912034UA (en) * 2017-02-08 2020-02-27 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130237481A1 (en) * 2010-08-17 2013-09-12 Vadim Kraynov Modified relaxin polypeptides and their uses
CN110225924A (zh) * 2017-01-25 2019-09-10 免疫医疗公司 松弛素融合多肽及其用途

Also Published As

Publication number Publication date
AU2021268355A1 (en) 2022-11-24
WO2021226439A3 (en) 2022-02-10
JP2023524981A (ja) 2023-06-14
WO2021226439A2 (en) 2021-11-11
US20230174610A1 (en) 2023-06-08
MX2022013770A (es) 2023-04-03
WO2021226439A8 (en) 2021-12-23
IL297951A (en) 2023-01-01
CA3180662A1 (en) 2021-11-11
EP4146681A2 (en) 2023-03-15
KR20230008791A (ko) 2023-01-16
EP4146681A4 (en) 2024-06-26

Similar Documents

Publication Publication Date Title
US20230174610A1 (en) Engineered relaxins and methods of use thereof
JP2022514465A (ja) 第ix因子を発現するレンチウイルスベクターの使用
JP7465378B2 (ja) Hiv融合体を標的とするポリペプチド
TW202122414A (zh) 治療性融合蛋白
US12509497B2 (en) Relaxin-2 fusion protein analogs and methods of using same
KR20190095925A (ko) 가령 황반 변성증 치료용 펩티드
WO2022258720A1 (en) Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection
IL310154A (en) Recombinant variants of r-spondin proteins and their use
JP2026506476A (ja) R-スポンジンタンパク質の組換えバリアントおよびその使用
JP2023509189A (ja) Rspo1タンパク質およびその使用
US20230091105A1 (en) Chimeric fusions between c4-binding protein c-terminal segment and angiopoietin-1 fibrinogen-like domain as angiopoietin mimetics and tie2 agonists to treat vascular diseases
US20230103583A1 (en) Method of enhancing aqueous humor outflow and reducing intraocular pressure
KR20210082189A (ko) Glp-2 융합 폴리펩티드 및 위장 병태를 치료 및 예방하기 위한 용도
CN117980323A (zh) R-spondin蛋白的重组变体及其用途
WO2023164266A2 (en) Dual checkpoint inhibitors and methods of using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination